Agrin Interactions at Neuromuscular Junction

No Pathway Network information available for Agrin Interactions at Neuromuscular Junction

Pathways in the Agrin Interactions at Neuromuscular Junction SuperPath

#	Name	Source	Genes
1	Agrin Interactions at Neuromuscular Junction	QIAGEN	ACTA1 ACTA2 ACTB ACTG1 ACTG2 AGRN ARHGEF6 ARHGEF7 CDC42 CHRNA1 CTTN DAG1 DVL1 EGFR ERBB2 ERBB3 ERBB4 GABPA HRAS ITGAD ITGAL ITGAM ITGAV ITGAX ITGB1 JUN KRAS LAMA2 MAPK1 MAPK10 MAPK3 MAPK8 MAPK9 MRAS MUSK NRAS NRG1 NRG2 NRG3 PAK1 PAK2 PAK3 PAK4 PAK5 PAK6 PTK2 PTK2B PXN RAC1 RAC2 RAC3 RAPSN RRAS RRAS2 SRC UTRN (see all 56) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	ACTA1	Actin Alpha 1, Skeletal Muscle	Protein Coding	1
2	ACTA2	Actin Alpha 2, Smooth Muscle	Protein Coding	1
3	ACTB	Actin Beta	Protein Coding	1
4	ACTG1	Actin Gamma 1	Protein Coding	1
5	ACTG2	Actin Gamma 2, Smooth Muscle	Protein Coding	1
6	AGRN	Agrin	Protein Coding	1
7	ARHGEF6	Rac/Cdc42 Guanine Nucleotide Exchange Factor 6	Protein Coding	1
8	ARHGEF7	Rho Guanine Nucleotide Exchange Factor 7	Protein Coding	1
9	CDC42	Cell Division Cycle 42	Protein Coding	1
10	CHRNA1	Cholinergic Receptor Nicotinic Alpha 1 Subunit	Protein Coding	1
11	DAG1	Dystroglycan 1	Protein Coding	1
12	DVL1	Dishevelled Segment Polarity Protein 1	Protein Coding	1
13	EGFR	Epidermal Growth Factor Receptor	Protein Coding	1
14	CTTN	Cortactin	Protein Coding	1
15	ERBB2	Erb-B2 Receptor Tyrosine Kinase 2	Protein Coding	1
16	ERBB3	Erb-B2 Receptor Tyrosine Kinase 3	Protein Coding	1
17	ERBB4	Erb-B2 Receptor Tyrosine Kinase 4	Protein Coding	1
18	GABPA	GA Binding Protein Transcription Factor Subunit Alpha	Protein Coding	1
19	HRAS	HRas Proto-Oncogene, GTPase	Protein Coding	1
20	ITGAD	Integrin Subunit Alpha D	Protein Coding	1
21	ITGAL	Integrin Subunit Alpha L	Protein Coding	1
22	ITGAM	Integrin Subunit Alpha M	Protein Coding	1
23	ITGAV	Integrin Subunit Alpha V	Protein Coding	1
24	ITGAX	Integrin Subunit Alpha X	Protein Coding	1
25	ITGB1	Integrin Subunit Beta 1	Protein Coding	1
26	JUN	Jun Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
27	KRAS	KRAS Proto-Oncogene, GTPase	Protein Coding	1
28	LAMA2	Laminin Subunit Alpha 2	Protein Coding	1
29	MAPK1	Mitogen-Activated Protein Kinase 1	Protein Coding	1
30	MAPK10	Mitogen-Activated Protein Kinase 10	Protein Coding	1
31	MAPK3	Mitogen-Activated Protein Kinase 3	Protein Coding	1
32	MAPK8	Mitogen-Activated Protein Kinase 8	Protein Coding	1
33	MAPK9	Mitogen-Activated Protein Kinase 9	Protein Coding	1
34	MRAS	Muscle RAS Oncogene Homolog	Protein Coding	1
35	MUSK	Muscle Associated Receptor Tyrosine Kinase	Protein Coding	1
36	NRAS	NRAS Proto-Oncogene, GTPase	Protein Coding	1
37	NRG1	Neuregulin 1	Protein Coding	1
38	NRG2	Neuregulin 2	Protein Coding	1
39	NRG3	Neuregulin 3	Protein Coding	1
40	PAK1	P21 (RAC1) Activated Kinase 1	Protein Coding	1
41	PAK2	P21 (RAC1) Activated Kinase 2	Protein Coding	1
42	PAK3	P21 (RAC1) Activated Kinase 3	Protein Coding	1
43	PAK4	P21 (RAC1) Activated Kinase 4	Protein Coding	1
44	PAK6	P21 (RAC1) Activated Kinase 6	Protein Coding	1
45	PAK5	P21 (RAC1) Activated Kinase 5	Protein Coding	1
46	PTK2	Protein Tyrosine Kinase 2	Protein Coding	1
47	PTK2B	Protein Tyrosine Kinase 2 Beta	Protein Coding	1
48	PXN	Paxillin	Protein Coding	1
49	RAC1	Rac Family Small GTPase 1	Protein Coding	1
50	RAC2	Rac Family Small GTPase 2	Protein Coding	1
51	RAC3	Rac Family Small GTPase 3	Protein Coding	1
52	RAPSN	Receptor Associated Protein Of The Synapse	Protein Coding	1
53	RRAS	RAS Related	Protein Coding	1
54	RRAS2	RAS Related 2	Protein Coding	1
55	SRC	SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase	Protein Coding	1
56	UTRN	Utrophin	Protein Coding	1

Disorders associated with Agrin Interactions at Neuromuscular Junction SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Noonan syndrome 1	Enrichment	HRAS, KRAS, MRAS, NRAS, RRAS, RRAS2	9.41
2	Lung non-small cell carcinoma	Enrichment	EGFR, ERBB2, HRAS, KRAS, NRAS	9.33
3	Rasopathy	Enrichment	HRAS, KRAS, MRAS, NRAS, RRAS2	7.21
4	Bladder cancer	Enrichment	EGFR, ERBB2, ERBB3, HRAS, KRAS	6.96
5	Postsynaptic congenital myasthenic syndromes	Enrichment	AGRN, CHRNA1, MUSK, RAPSN	6.90
6	Lung cancer susceptibility 3	Enrichment	ACTA2, EGFR, ERBB2, KRAS	6.60
7	Schimmelpenning-feuerstein-mims syndrome	Enrichment	HRAS, KRAS, NRAS	6.58
8	Nevus, epidermal	Enrichment	HRAS, KRAS, NRAS	5.64
9	Non-immune hydrops fetalis	Enrichment	ACTA1, CHRNA1, HRAS, KRAS	5.12
10	Lung cancer	Enrichment	ACTA2, EGFR, ERBB2, KRAS	5.07
11	Juvenile myelomonocytic leukemia	Enrichment	KRAS, NRAS, RRAS	4.85
12	Ras-associated autoimmune leukoproliferative disorder	Enrichment	KRAS, NRAS	4.78
13	Baraitser-winter cerebrofrontofacial syndrome	Enrichment	ACTB, ACTG1	4.78
14	Congenital myasthenic syndrome	Enrichment	AGRN, CHRNA1, RAPSN	4.63
15	Noonan syndrome and noonan-related syndrome	Enrichment	HRAS, KRAS, NRAS	4.53
16	Large congenital melanocytic nevus	Enrichment	HRAS, NRAS	4.30
17	Chronic myelogenous leukemia, bcr-abl1 positive	Enrichment	KRAS, NRAS	4.00
18	Hydrops fetalis, nonimmune	Enrichment	ACTA1, CHRNA1, HRAS	3.79
19	Hirschsprung disease 1	Enrichment	ERBB2, ERBB3, NRG3	3.65
20	Differentiated thyroid carcinoma	Enrichment	HRAS, KRAS, NRAS	3.65
21	Lung squamous cell carcinoma	Enrichment	EGFR, KRAS	3.60
22	Thyroid cancer, nonmedullary, 2	Enrichment	HRAS, NRAS	3.46
23	Leukemia, chronic myeloid	Enrichment	KRAS, NRAS	3.46
24	Noonan syndrome 3	Enrichment	HRAS, KRAS	3.46
25	Follicular thyroid carcinoma	Enrichment	HRAS, NRAS	3.46
26	Melanocytic nevus syndrome, congenital	Enrichment	HRAS, NRAS	3.34
27	Multiple pterygium syndrome, lethal type	Enrichment	CHRNA1, RAPSN	3.34
28	Fetal akinesia deformation sequence 1	Enrichment	ACTA1, MUSK, RAPSN	3.33
29	Myasthenic syndrome, congenital, 4c, associated with acetylcholine receptor deficiency	Enrichment	MUSK, RAPSN	3.13
30	Ovarian cancer	Enrichment	EGFR, ERBB2, KRAS, RRAS2	3.10
31	Lip and oral cavity carcinoma	Enrichment	EGFR, HRAS	2.97
32	Microcephaly	Enrichment	ACTB, ACTG1, MAPK1, PAK3	2.78
33	Creatine phosphokinase, elevated serum	Enrichment	DAG1, LAMA2	2.71
34	Isolated elevated serum creatine phosphokinase levels	Enrichment	DAG1, LAMA2	2.71
35	Arteriovenous malformations of the brain	Enrichment	EGFR, KRAS	2.56
36	Congenital myopathy	Enrichment	ACTA1, CHRNA1	2.56
37	Centronuclear myopathy	Enrichment	ACTA1, CHRNA1	2.48
38	Erythroleukemia, familial	Enrichment	ERBB3	2.38
39	Paget disease, extramammary	Enrichment	ERBB2	2.38
40	Baraitser-winter syndrome 1	Enrichment	ACTB	2.38
41	Oculoectodermal syndrome	Enrichment	KRAS	2.38
42	Intellectual developmental disorder, x-linked 30	Enrichment	PAK3	2.38
43	Systemic lupus erythematosus 6	Enrichment	ITGAM	2.38
44	Immunodeficiency 73a with defective neutrophil chemotaxis and leukocytosis	Enrichment	RAC2	2.38
45	Congenital myopathy 2a, typical, autosomal dominant	Enrichment	ACTA1	2.38
46	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	Enrichment	RAPSN	2.38
47	Muscular dystrophy-dystroglycanopathy , type a, 9	Enrichment	DAG1	2.38
48	Melanosis, neurocutaneous	Enrichment	NRAS	2.38
49	Myopathy, scapulohumeroperoneal	Enrichment	ACTA1	2.38
50	Lethal congenital contracture syndrome 2	Enrichment	ERBB3	2.38
51	Noonan syndrome 6	Enrichment	NRAS	2.38
52	Fetal akinesia deformation sequence 2	Enrichment	RAPSN	2.38
53	Noonan syndrome 11	Enrichment	MRAS	2.38
54	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5	Enrichment	ACTG2	2.38
55	Visceral neuropathy, familial, 2, autosomal recessive	Enrichment	ERBB2	2.38
56	Noonan syndrome 13	Enrichment	MAPK1	2.38
57	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	Enrichment	MUSK	2.38
58	Knobloch syndrome 2	Enrichment	PAK2	2.38
59	Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies	Enrichment	RAC3	2.38
60	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	Enrichment	PAK1	2.38
61	Congenital smooth muscle hamartoma, with or without hemihypertrophy	Enrichment	ACTB	2.38
62	Intellectual developmental disorder, x-linked 46	Enrichment	ARHGEF6	2.38
63	Immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia	Enrichment	RAC2	2.38
64	Cardiofaciocutaneous syndrome 2	Enrichment	KRAS	2.38
65	Becker nevus syndrome	Enrichment	ACTB	2.38
66	Dystonia-deafness syndrome 1	Enrichment	ACTB	2.38
67	Visceral neuropathy, familial, 3, autosomal dominant	Enrichment	ACTG2	2.38
68	Congenital myopathy 2b, severe infantile, autosomal recessive	Enrichment	ACTA1	2.38
69	Amyotrophic lateral sclerosis 19	Enrichment	ERBB4	2.38
70	Autosomal dominant familial visceral neuropathy	Enrichment	ACTG2	2.38
71	Muscular dystrophy-dystroglycanopathy , type c, 9	Enrichment	DAG1	2.38
72	Thrombocytopenia 6	Enrichment	SRC	2.38
73	Takenouchi-kosaki syndrome	Enrichment	CDC42	2.38
74	Congenital myopathy 2c, severe infantile, autosomal dominant	Enrichment	ACTA1	2.38
75	Thrombocytopenia 8, with dysmorphic features and developmental delay	Enrichment	ACTB	2.38
76	Immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia	Enrichment	RAC2	2.38
77	Baraitser-winter syndrome	Enrichment	ACTB	2.38
78	Congenital pulmonary airway malformation	Enrichment	KRAS	2.38
79	Immune dysregulation, neurodevelopmental defects, and colitis	Enrichment	ITGAV	2.38
80	Zebra body myopathy	Enrichment	ACTA1	2.38
81	Infantile lad-like disease due to rac2 deficiency	Enrichment	RAC2	2.38
82	Congenital smooth muscle hamartoma	Enrichment	ACTB	2.38
83	Reticular dysgenesis-like severe combined immunodeficiency	Enrichment	RAC2	2.38
84	Nocarh syndrome	Enrichment	CDC42	2.38
85	Developmental malformations-deafness-dystonia syndrome	Enrichment	ACTB	2.38
86	Muscle-eye-brain disease with bilateral multicystic leucodystrophy	Enrichment	DAG1	2.38
87	Phakomatosis pigmentokeratotica	Enrichment	HRAS	2.38
88	Actin-accumulation myopathy	Enrichment	ACTA1	2.38
89	Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom	Enrichment	RAC1	2.38
90	Myopathic intestinal pseudoobstruction	Enrichment	ACTG2	2.38
91	Rac2-related combined immunodeficiency-bronchiectasis-cancer-predisposing syndrome	Enrichment	RAC2	2.38
92	Serous carcinoma of the corpus uteri	Enrichment	ERBB2	2.38
93	Neurocutaneous melanocytosis	Enrichment	NRAS	2.38
94	Actg2 visceral myopathy	Enrichment	ACTG2	2.38
95	Laminin subunit alpha 2-related muscular dystrophy	Enrichment	LAMA2	2.38
96	Colorectal cancer	Enrichment	ERBB2, NRAS, SRC	2.26
97	Costello syndrome	Enrichment	HRAS	2.08
98	Visceral neuropathy, familial, 1, autosomal recessive	Enrichment	ERBB3	2.08
99	Aortic aneurysm, familial thoracic 2	Enrichment	ACTA2	2.08
100	Deafness, autosomal dominant 20	Enrichment	ACTG1	2.08
101	Smooth muscle dysfunction syndrome	Enrichment	ACTA2	2.08
102	Encephalocraniocutaneous lipomatosis	Enrichment	KRAS	2.08
103	Aortic aneurysm, familial thoracic 6	Enrichment	ACTA2	2.08
104	Baraitser-winter syndrome 2	Enrichment	ACTG1	2.08
105	Moyamoya disease 5	Enrichment	ACTA2	2.08
106	Intellectual developmental disorder, autosomal dominant 48	Enrichment	RAC1	2.08
107	Noonan syndrome 12	Enrichment	RRAS2	2.08
108	Immune system disease	Enrichment	CDC42	2.08
109	Intestinal obstruction	Enrichment	ACTG2	2.08
110	Wooly hair nevus	Enrichment	HRAS	2.08
111	Leukemia, acute myeloid	Enrichment	KRAS, NRAS	1.93
112	Myopathy	Enrichment	ACTA1, RAPSN	1.93
113	Muscular dystrophy, duchenne type	Enrichment	UTRN	1.91
114	Langerhans cell histiocytosis	Enrichment	NRAS	1.91
115	Muscular dystrophy, congenital merosin-deficient, 1a	Enrichment	LAMA2	1.91
116	Neonatal nephrocutaneous inflammatory syndrome	Enrichment	EGFR	1.91
117	Bronchopulmonary dysplasia	Enrichment	MUSK	1.91
118	Spermatocytoma	Enrichment	HRAS	1.91
119	Neonatal inflammatory skin and bowel disease	Enrichment	EGFR	1.91
120	Lama2-related muscular dystrophy	Enrichment	LAMA2	1.91
121	Distal arthrogryposis	Enrichment	ACTA1, RAPSN	1.89
122	Gastric cancer	Enrichment	ERBB2, KRAS	1.87
123	Cardiofaciocutaneous syndrome 1	Enrichment	KRAS	1.78
124	Diffuse gastric and lobular breast cancer syndrome	Enrichment	KRAS	1.78
125	Nemaline myopathy 2	Enrichment	ACTA1	1.78
126	Robinow syndrome, autosomal dominant 1	Enrichment	DVL1	1.78
127	Megacystis-microcolon-intestinal hypoperistalsis syndrome 1	Enrichment	ACTG2	1.78
128	Autoimmune lymphoproliferative syndrome	Enrichment	ACTA2	1.78
129	Chromosome 22q11.2 deletion syndrome, distal	Enrichment	MAPK1	1.78
130	Myasthenic syndrome, congenital, 1b, fast-channel	Enrichment	CHRNA1	1.78
131	Barrett esophagus	Enrichment	ERBB2	1.78
132	Aminoacylase 1 deficiency	Enrichment	ACTB	1.78
133	Cardiofaciocutaneous syndrome	Enrichment	KRAS	1.78
134	Lung sarcomatoid carcinoma	Enrichment	KRAS	1.78
135	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	Enrichment	CDC42	1.78
136	Pilocytic astrocytoma	Enrichment	KRAS	1.78
137	Epidermolytic nevus	Enrichment	HRAS	1.78
138	Autosomal dominant robinow syndrome	Enrichment	DVL1	1.78
139	Knobloch syndrome	Enrichment	PAK2	1.78
140	Intermediate nemaline myopathy	Enrichment	ACTA1	1.78
141	Pseudomyogenic hemangioendothelioma	Enrichment	ACTB	1.78
142	Visceral myopathy 1	Enrichment	ACTG2	1.69
143	Congenital myopathy 3 with rigid spine	Enrichment	ACTA1	1.69
144	Robinow syndrome, autosomal recessive 1	Enrichment	DVL1	1.69
145	Knobloch syndrome 1	Enrichment	PAK2	1.69
146	Mosaic variegated aneuploidy syndrome 1	Enrichment	PAK6	1.69
147	Myasthenic syndrome, congenital, 8	Enrichment	AGRN	1.69
148	Robinow syndrome, autosomal dominant 2	Enrichment	DVL1	1.69
149	Muscular dystrophy, limb-girdle, autosomal recessive 23	Enrichment	LAMA2	1.69
150	Coloboma of choroid and retina	Enrichment	ACTG1	1.69
151	Severe congenital nemaline myopathy	Enrichment	ACTA1	1.69
152	Cowden syndrome 1	Enrichment	EGFR	1.61
153	Moyamoya disease 1	Enrichment	ACTA2	1.61
154	Autosomal recessive robinow syndrome	Enrichment	DVL1	1.61
155	Intestinal pseudo-obstruction	Enrichment	ACTG2	1.61
156	Breast adenocarcinoma	Enrichment	KRAS	1.61
157	Typical nemaline myopathy	Enrichment	ACTA1	1.61
158	Myelofibrosis	Enrichment	SRC	1.54
159	Squamous cell carcinoma, head and neck	Enrichment	EGFR	1.54
160	Myasthenic syndrome, congenital, 1a, slow-channel	Enrichment	CHRNA1	1.54
161	Capillary malformation-arteriovenous malformation 1	Enrichment	KRAS	1.54
162	Gallbladder cancer	Enrichment	KRAS	1.54
163	Pilomyxoid astrocytoma	Enrichment	KRAS	1.54
164	Childhood-onset nemaline myopathy	Enrichment	ACTA1	1.54
165	Glioma susceptibility 1	Enrichment	ERBB2	1.49
166	Lennox-gastaut syndrome	Enrichment	MAPK10	1.49
167	Congenital muscular dystrophy	Enrichment	LAMA2	1.49
168	Mosaic variegated aneuploidy syndrome	Enrichment	PAK6	1.49
169	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	Enrichment	RAC1	1.44
170	Arteriovenous malformation	Enrichment	HRAS	1.44
171	Hydrops fetalis	Enrichment	RAPSN	1.44
172	Breast cancer	Enrichment	JUN, KRAS	1.42
173	Cat eye syndrome	Enrichment	ACTG1	1.39
174	Myopathy, x-linked, with excessive autophagy	Enrichment	HRAS	1.39
175	Nemaline myopathy	Enrichment	ACTA1	1.39
176	Dilated cardiomyopathy	Enrichment	ACTA1, LAMA2	1.37
177	Specific learning disability	Enrichment	MAPK1	1.35
178	Presynaptic congenital myasthenic syndromes	Enrichment	AGRN	1.35
179	Neural tube defects	Enrichment	ITGB1	1.28
180	Protein-deficiency anemia	Enrichment	NRAS	1.28
181	Nk-cell enteropathy	Enrichment	ERBB4	1.28
182	Osteoporosis	Enrichment	SRC	1.25
183	Walker-warburg syndrome	Enrichment	DAG1	1.25
184	Congenital myopathy 4a, autosomal dominant	Enrichment	ACTA1	1.22
185	Lynch syndrome	Enrichment	KRAS	1.22
186	Rhabdomyosarcoma	Enrichment	HRAS	1.19
187	Gliosarcoma	Enrichment	EGFR	1.19
188	Giant cell glioblastoma	Enrichment	EGFR	1.17
189	Heart, malformation of	Enrichment	MAPK1	1.14
190	Neuromuscular disease	Enrichment	ACTA1	1.14
191	Lissencephaly	Enrichment	ACTG1	1.08
192	Complex neurodevelopmental disorder	Enrichment	PAK3, RAC3	1.03
193	Pancreatic cancer	Enrichment	KRAS	1.01
194	Severe covid-19	Enrichment	ITGAV	0.95
195	Connective tissue disease	Enrichment	ACTA2	0.91
196	Cakut	Enrichment	ACTG1	0.88
197	Non-syndromic x-linked intellectual disability	Enrichment	ARHGEF6	0.86
198	Non-syndromic genetic deafness	Enrichment	ACTG1	0.86
199	Systemic lupus erythematosus	Enrichment	ITGAM	0.83
200	Charcot-marie-tooth disease	Enrichment	LAMA2	0.81
201	Nonsyndromic hearing loss	Enrichment	ACTG1	0.80
202	Familial thoracic aortic aneurysm and aortic dissection	Enrichment	ACTA2	0.78
203	Hereditary breast carcinoma	Enrichment	KRAS	0.78
204	Thrombocytopenia	Enrichment	SRC	0.74
205	Autosomal dominant non-syndromic intellectual disability	Enrichment	ERBB4	0.73
206	Rare autosomal dominant non-syndromic sensorineural deafness type dfna	Enrichment	ACTG1	0.71
207	Hereditary breast ovarian cancer syndrome	Enrichment	KRAS	0.69
208	Myeloma, multiple	Enrichment	KRAS	0.68
209	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7	Enrichment	ERBB4	0.67
210	Autism	Enrichment	CHRNA1	0.59
211	Rare genetic deafness	Enrichment	ACTG1	0.55
212	Inherited cancer-predisposing syndrome	Enrichment	EGFR	0.37

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Agrin Interactions at Neuromuscular Junction

Pathway Network for Agrin Interactions at Neuromuscular Junction

Member Pathways for Agrin Interactions at Neuromuscular Junction

Pathways in the Agrin Interactions at Neuromuscular Junction SuperPath

Associated Genes for Agrin Interactions at Neuromuscular Junction

Associated Disorders for Agrin Interactions at Neuromuscular Junction

Disorders associated with Agrin Interactions at Neuromuscular Junction SuperPath

STRING Interaction Network for Agrin Interactions at Neuromuscular Junction

Sources for Agrin Interactions at Neuromuscular Junction